IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BML Capital Management, LLC

Q4 2025 Holdings

Filed 2026-02-03 | 16 holdings | $115.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics Inc(ACRS)COM00461U105$42.9M14,250,00037.1%
Atea Pharmaceuticals Inc(AVIR)COM04683R106$26.7M7,490,00023.1%
Oramed Pharmaceuticals Inc(ORMP)COM NEW68403P203$9.0M3,167,2317.8%
Instil BIO Inc(TIL)COM NEW45783C200$7.1M645,6006.1%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$6.6M5,292,0005.7%
Carmax Inc(KMX)COM143130102$6.0M155,0005.2%
Kezar Life Sciences Inc(KZR)COM NEW49372L209$4.5M720,7873.9%
Target Corp(TGT)COM87612E106$3.7M37,5003.2%
Carvana Co(CVNA)PutCL A146869102$2.0M1501.7%
Outset MED Inc(OM)COM NEW690145206$2.0M543,1801.7%
Pliant Therapeutics Inc(PLRX)COM729139105$1.9M1,546,1371.6%
Imagenebio Inc(IMA)COM45175G207$1.2M177,0261.1%
Connect Biopharma Hldgs LTD(CNTB)SHSG23549101$1.2M408,8871.0%
Walmart Inc(WMT)PutCOM931142103$492.5K3350.4%
Tesla Inc(TSLA)PutCOM88160R101$205.0K1,0000.2%
Lisata Therapeutics Inc(LSTA)COM128058302$136.4K73,3480.1%